United States Dabigatran Market Report 2016

December 2016 | 98 pages | ID: UBB13CFADA6EN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Dabigatran

Revenue, means the sales value of Dabigatran

This report studies sales (consumption) of Dabigatran in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering

• Boehringer Ingelheim
• Bayer
• Janssen (Johnson & Johnson)
• Bristol-Myers Squibb
• Pfizer
• Daiichi-Sankyo
• Portola Pharmaceuticals
• Smiths Medical

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

• Type I
• Type II
• Type III

Split by applications, this report focuses on sales, market share and growth rate of Dabigatran in each application, can be divided into

• Application 1
• Application 2
• Application 3

Contents

United States Dabigatran Market Report 2016

1 DABIGATRAN OVERVIEW

1.1 Product Overview and Scope of Dabigatran
1.2 Classification of Dabigatran
  1.2.1 Type I
  1.2.2 Type II
  1.2.3 Type III
1.3 Application of Dabigatran
  1.3.1 Application
  1.3.2 Application
  1.3.3 Application
1.4 United States Market Size Sales (Value) and Revenue (Volume) of Dabigatran (2011-2021)
  1.4.1 United States Dabigatran Sales and Growth Rate (2011-2021)
  1.4.2 United States Dabigatran Revenue and Growth Rate (2011-2021)

2 UNITED STATES DABIGATRAN COMPETITION BY MANUFACTURERS

2.1 United States Dabigatran Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Dabigatran Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Dabigatran Average Price by Manufactures (2015 and 2016)
2.4 Dabigatran Market Competitive Situation and Trends
  2.4.1 Dabigatran Market Concentration Rate
  2.4.2 Dabigatran Market Share of Top 3 and Top 5 Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion

3 UNITED STATES DABIGATRAN SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (2011-2016)

3.1 United States Dabigatran Sales and Market Share by Type (2011-2016)
3.2 United States Dabigatran Revenue and Market Share by Type (2011-2016)
3.3 United States Dabigatran Price by Type (2011-2016)
3.4 United States Dabigatran Sales Growth Rate by Type (2011-2016)

4 UNITED STATES DABIGATRAN SALES (VOLUME) BY APPLICATION (2011-2016)

4.1 United States Dabigatran Sales and Market Share by Application (2011-2016)
4.2 United States Dabigatran Sales Growth Rate by Application (2011-2016)
4.3 Market Drivers and Opportunities

5 UNITED STATES DABIGATRAN MANUFACTURERS PROFILES/ANALYSIS

5.1 Boehringer Ingelheim
  5.1.1 Company Basic Information, Manufacturing Base and Competitors
  5.1.2 Dabigatran Product Type, Application and Specification
    5.1.2.1 Type I
    5.1.2.2 Type II
  5.1.3 Boehringer Ingelheim Dabigatran Sales, Revenue, Price and Gross Margin (2011-2016)
  5.1.4 Main Business/Business Overview
5.2 Bayer
  5.2.2 Dabigatran Product Type, Application and Specification
    5.2.2.1 Type I
    5.2.2.2 Type II
  5.2.3 Bayer Dabigatran Sales, Revenue, Price and Gross Margin (2011-2016)
  5.2.4 Main Business/Business Overview
5.3 Janssen (Johnson & Johnson)
  5.3.2 Dabigatran Product Type, Application and Specification
    5.3.2.1 Type I
    5.3.2.2 Type II
  5.3.3 Janssen (Johnson & Johnson) Dabigatran Sales, Revenue, Price and Gross Margin (2011-2016)
  5.3.4 Main Business/Business Overview
5.4 Bristol-Myers Squibb
  5.4.2 Dabigatran Product Type, Application and Specification
    5.4.2.1 Type I
    5.4.2.2 Type II
  5.4.3 Bristol-Myers Squibb Dabigatran Sales, Revenue, Price and Gross Margin (2011-2016)
  5.4.4 Main Business/Business Overview
5.5 Pfizer
  5.5.2 Dabigatran Product Type, Application and Specification
    5.5.2.1 Type I
    5.5.2.2 Type II
  5.5.3 Pfizer Dabigatran Sales, Revenue, Price and Gross Margin (2011-2016)
  5.5.4 Main Business/Business Overview
5.6 Daiichi-Sankyo
  5.6.2 Dabigatran Product Type, Application and Specification
    5.6.2.1 Type I
    5.6.2.2 Type II
  5.6.3 Daiichi-Sankyo Dabigatran Sales, Revenue, Price and Gross Margin (2011-2016)
  5.6.4 Main Business/Business Overview
5.7 Portola Pharmaceuticals
  5.7.2 Dabigatran Product Type, Application and Specification
    5.7.2.1 Type I
    5.7.2.2 Type II
  5.7.3 Portola Pharmaceuticals Dabigatran Sales, Revenue, Price and Gross Margin (2011-2016)
  5.7.4 Main Business/Business Overview
5.8 Smiths Medical
  5.8.2 Dabigatran Product Type, Application and Specification
    5.8.2.1 Type I
    5.8.2.2 Type II
  5.8.3 Smiths Medical Dabigatran Sales, Revenue, Price and Gross Margin (2011-2016)
  5.8.4 Main Business/Business Overview

6 DABIGATRAN MANUFACTURING COST ANALYSIS

6.1 Dabigatran Key Raw Materials Analysis
  6.1.1 Key Raw Materials
  6.1.2 Price Trend of Key Raw Materials
  6.1.3 Key Suppliers of Raw Materials
  6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
  6.2.1 Raw Materials
  6.2.2 Labor Cost
  6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of Dabigatran

7 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

7.1 Dabigatran Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of Dabigatran Major Manufacturers in 2015
7.4 Downstream Buyers

8 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

8.1 Marketing Channel
  8.1.1 Direct Marketing
  8.1.2 Indirect Marketing
  8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
  8.2.1 Pricing Strategy
  8.2.2 Brand Strategy
  8.2.3 Target Client
8.3 Distributors/Traders List

9 MARKET EFFECT FACTORS ANALYSIS

9.1 Technology Progress/Risk
  9.1.1 Substitutes Threat
  9.1.2 Technology Progress in Related Industry
9.2 Consumer Needs/Customer Preference Change
9.3 Economic/Political Environmental Change

10 UNITED STATES DABIGATRAN MARKET FORECAST (2016-2021)

10.1 United States Dabigatran Sales, Revenue Forecast (2016-2021)
10.2 United States Dabigatran Sales Forecast by Type (2016-2021)
10.3 United States Dabigatran Sales Forecast by Application (2016-2021)
10.4 Dabigatran Price Forecast (2016-2021)

11 RESEARCH FINDINGS AND CONCLUSION

12 APPENDIX

Disclosure Section
Research Methodology
Data Source
Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Dabigatran
Table Classification of Dabigatran
Figure United States Sales Market Share of Dabigatran by Type in 2015
Table Application of Dabigatran
Figure United States Sales Market Share of Dabigatran by Application in 2015
Figure United States Dabigatran Sales and Growth Rate (2011-2021)
Figure United States Dabigatran Revenue and Growth Rate (2011-2021)
Table United States Dabigatran Sales of Key Manufacturers (2015 and 2016)
Table United States Dabigatran Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Dabigatran Sales Share by Manufacturers
Figure 2016 Dabigatran Sales Share by Manufacturers
Table United States Dabigatran Revenue by Manufacturers (2015 and 2016)
Table United States Dabigatran Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Dabigatran Revenue Share by Manufacturers
Table 2016 United States Dabigatran Revenue Share by Manufacturers
Table United States Market Dabigatran Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Dabigatran Average Price of Key Manufacturers in 2015
Figure Dabigatran Market Share of Top 3 Manufacturers
Figure Dabigatran Market Share of Top 5 Manufacturers
Table United States Dabigatran Sales by Type (2011-2016)
Table United States Dabigatran Sales Share by Type (2011-2016)
Figure United States Dabigatran Sales Market Share by Type in 2015
Table United States Dabigatran Revenue and Market Share by Type (2011-2016)
Table United States Dabigatran Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Dabigatran by Type (2011-2016)
Table United States Dabigatran Price by Type (2011-2016)
Figure United States Dabigatran Sales Growth Rate by Type (2011-2016)
Table United States Dabigatran Sales by Application (2011-2016)
Table United States Dabigatran Sales Market Share by Application (2011-2016)
Figure United States Dabigatran Sales Market Share by Application in 2015
Table United States Dabigatran Sales Growth Rate by Application (2011-2016)
Figure United States Dabigatran Sales Growth Rate by Application (2011-2016)
Table Boehringer Ingelheim Basic Information List
Table Boehringer Ingelheim Dabigatran Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Boehringer Ingelheim Dabigatran Sales Market Share (2011-2016)
Table Bayer Basic Information List
Table Bayer Dabigatran Sales, Revenue, Price and Gross Margin (2011-2016)
Table Bayer Dabigatran Sales Market Share (2011-2016)
Table Janssen (Johnson & Johnson) Basic Information List
Table Janssen (Johnson & Johnson) Dabigatran Sales, Revenue, Price and Gross Margin (2011-2016)
Table Janssen (Johnson & Johnson) Dabigatran Sales Market Share (2011-2016)
Table Bristol-Myers Squibb Basic Information List
Table Bristol-Myers Squibb Dabigatran Sales, Revenue, Price and Gross Margin (2011-2016)
Table Bristol-Myers Squibb Dabigatran Sales Market Share (2011-2016)
Table Pfizer Basic Information List
Table Pfizer Dabigatran Sales, Revenue, Price and Gross Margin (2011-2016)
Table Pfizer Dabigatran Sales Market Share (2011-2016)
Table Daiichi-Sankyo Basic Information List
Table Daiichi-Sankyo Dabigatran Sales, Revenue, Price and Gross Margin (2011-2016)
Table Daiichi-Sankyo Dabigatran Sales Market Share (2011-2016)
Table Portola Pharmaceuticals Basic Information List
Table Portola Pharmaceuticals Dabigatran Sales, Revenue, Price and Gross Margin (2011-2016)
Table Portola Pharmaceuticals Dabigatran Sales Market Share (2011-2016)
Table Smiths Medical Basic Information List
Table Smiths Medical Dabigatran Sales, Revenue, Price and Gross Margin (2011-2016)
Table Smiths Medical Dabigatran Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Dabigatran
Figure Manufacturing Process Analysis of Dabigatran
Figure Dabigatran Industrial Chain Analysis
Table Raw Materials Sources of Dabigatran Major Manufacturers in 2015
Table Major Buyers of Dabigatran
Table Distributors/Traders List
Figure United States Dabigatran Production and Growth Rate Forecast (2016-2021)
Figure United States Dabigatran Revenue and Growth Rate Forecast (2016-2021)
Table United States Dabigatran Production Forecast by Type (2016-2021)
Table United States Dabigatran Consumption Forecast by Application (2016-2021)